BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp Grows Stock Position in Bath & Body Works, Inc. (NYSE:BBWI)

BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp lifted its holdings in shares of Bath & Body Works, Inc. (NYSE:BBWI) by 59.8% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 40,920 shares of the company’s stock after purchasing an additional 15,306 shares during the period. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp’s holdings in Bath & Body Works were worth $1,598,000 as of its most recent SEC filing.

A number of other institutional investors also recently made changes to their positions in the stock. First Community Trust NA acquired a new stake in Bath & Body Works during the second quarter worth approximately $30,000. GAMMA Investing LLC increased its stake in Bath & Body Works by 75.7% during the 1st quarter. GAMMA Investing LLC now owns 1,116 shares of the company’s stock worth $56,000 after buying an additional 481 shares during the period. TFO Wealth Partners LLC increased its position in shares of Bath & Body Works by 9,664.7% during the fourth quarter. TFO Wealth Partners LLC now owns 1,660 shares of the company’s stock worth $72,000 after acquiring an additional 1,643 shares during the last quarter. Quarry LP increased its holdings in Bath & Body Works by 289.4% during the 4th quarter. Quarry LP now owns 1,690 shares of the company’s stock worth $73,000 after purchasing an additional 1,256 shares during the last quarter. Finally, EntryPoint Capital LLC raised its holdings in Bath & Body Works by 224.0% in the first quarter. EntryPoint Capital LLC now owns 1,471 shares of the company’s stock valued at $74,000 after acquiring an additional 1,017 shares in the last quarter. 95.14% of the stock is owned by institutional investors and hedge funds.

Bath & Body Works Trading Up 2.0 %

Shares of NYSE:BBWI opened at $32.39 on Monday. Bath & Body Works, Inc. has a 1-year low of $26.20 and a 1-year high of $52.99. The business’s 50 day moving average is $31.85 and its 200-day moving average is $40.24. The firm has a market capitalization of $7.23 billion, a PE ratio of 8.35, a PEG ratio of 0.96 and a beta of 1.77.

Bath & Body Works (NYSE:BBWI) last announced its quarterly earnings results on Wednesday, August 28th. The company reported $0.37 earnings per share for the quarter, beating analysts’ consensus estimates of $0.35 by $0.02. The firm had revenue of $1.53 billion for the quarter, compared to analysts’ expectations of $1.54 billion. Bath & Body Works had a negative return on equity of 41.94% and a net margin of 12.69%. On average, sell-side analysts predict that Bath & Body Works, Inc. will post 3.18 EPS for the current year.

Bath & Body Works Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 6th. Shareholders of record on Friday, August 23rd were given a $0.20 dividend. The ex-dividend date was Friday, August 23rd. This represents a $0.80 annualized dividend and a yield of 2.47%. Bath & Body Works’s payout ratio is 20.62%.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on the stock. Piper Sandler decreased their price objective on shares of Bath & Body Works from $47.00 to $39.00 and set a “neutral” rating for the company in a report on Thursday, July 11th. UBS Group cut their price target on Bath & Body Works from $52.00 to $38.00 and set a “neutral” rating on the stock in a report on Thursday, August 29th. Raymond James reduced their price objective on shares of Bath & Body Works from $51.00 to $42.00 and set an “outperform” rating for the company in a report on Thursday, August 29th. Evercore ISI dropped their target price on Bath & Body Works from $45.00 to $35.00 and set an “in-line” rating on the stock in a report on Wednesday, August 28th. Finally, Wells Fargo & Company dropped their price target on shares of Bath & Body Works from $48.00 to $40.00 and set an “equal weight” rating on the stock in a research report on Wednesday, July 24th. Eight research analysts have rated the stock with a hold rating and nine have given a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $42.35.

Bath & Body Works Company Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.